Torsekar: Trump's Copper Tariff is a First Step. Here's What's Needed Now to Counter China

Torsekar: Trump’s Copper Tariff is a First Step. Here’s What’s Needed Now to Counter China

With President Donald Trump’s recent announcement of 50% tariffs on copper imports under Section 232 of the Trade Expansion Act, the United States has correctly identified copper as a material of strategic national importance.

CPA Supports FEOC Excise Tax in President Trump’s “One Big Beautiful Bill” to Strengthen U.S. Solar Industry and National Security

CPA Supports FEOC Excise Tax in President Trump’s “One Big Beautiful Bill” to Strengthen U.S. Solar Industry and National Security

CPA strongly endorses the FEOC Excise Tax in the Senate reconciliation bill as a critical step in protecting America’s solar manufacturing industry from reliance on subsidized and compromised Chinese components.

Rechenberg: Thanks to Imported Drugs, America Has Lost Control of Its Medicine Cabinet

Rechenberg: Thanks to Imported Drugs, America Has Lost Control of Its Medicine Cabinet

America is facing a growing crisis in its medical system — not from a lack of talent or innovation, but from a breakdown in the control, safety and supply of essential medicine. Our growing reliance on imports is now driving serious drug shortages, destabilizing supply chains and increasingly making medications unsafe.

CPA Applauds Commerce Department’s Final Determinations Confirming China’s Rampant Trade Violations in Solar Imports from Southeast Asia

CPA Applauds Commerce Department’s Final Determinations Confirming China’s Rampant Trade Violations in Solar Imports from Southeast Asia

The Department’s decision confirms what CPA has consistently warned: Chinese solar companies have been illegally circumventing U.S. trade laws through Southeast Asian shell operations, flooding the U.S. market with dumped and subsidized products directly harming the domestic solar manufacturing industry.

America’s generic drug crisis demands investment, not dependence

America’s Generic Drug Crisis Demands Investment, Not Dependence

The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on foreign manufacturers for generic drugs is at the center of it.

What the National Institutes of Health Does for the Economy and the Health of Our Citizens

What the National Institutes of Health Does for the Economy and the Health of Our Citizens

The National Institutes of Health (NIH) is today the main source of new drugs in this country – indeed the world, because America leads in the field. It has a critical importance to America’s health. Less well known is its huge, positive, economic impact.